World's Best Scientists 2026 revealed!
Award Badge
Medicine
Switzerland
2023

D-Index & Metrics

Medicine

D-Index
122
Citations
62294
World Ranking
3442
National Ranking
43

Research.com Recognitions

  • 2023 - Research.com Medicine in Switzerland Leader Award

Overview

Oliver Distler is affiliated with the University of Zurich in Switzerland and has a publication record primarily in the field of Medicine, with a focus on subfields such as Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Epidemiology, Rheumatology, and Immunology.

The main topics of their research encompass:

  • Systemic Sclerosis and Related Diseases
  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Inflammatory Myopathies and Dermatomyositis
  • Dermatologic Treatments and Research
  • Mast cells and histamine
  • Pulmonary Hypertension Research and Treatments
  • Rheumatoid Arthritis Research and Therapies

Frequent co-authors in Oliver Distler's work include:

  • Yannick Allanore
  • Anna-Maria Hoffmann-Vold
  • Masataka Kuwana
  • Marco Matucci-Cerinic
  • Cosimo Bruni

They have contributed publications to a variety of journals, with multiple works appearing in these venues:

  • Annals of the Rheumatic Diseases
  • Lara D. Veeken
  • RMD Open
  • The Lancet Rheumatology
  • Arthritis Research & Therapy

Oliver Distler's recent papers include:

  • "Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial" (2020, The Lancet Respiratory Medicine)
  • "Standardisation of nailfold capillaroscopy for the assessment of patients with Raynaud's phenomenon and systemic sclerosis" (2020, Autoimmunity Reviews)
  • "Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database" (2020, Annals of the Rheumatic Diseases)
  • "COMPERA 2.0: a refined four-stratum risk assessment model for pulmonary arterial hypertension" (2021, European Respiratory Journal)
  • "The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements" (2020, The Lancet Rheumatology)

In addition to journal articles, Oliver Distler has also published a book titled Pulmonary Fibrosis: One Manifestation, Various Diseases in 2022, released by Frontiers Media.

Best Publications

  • 2013 classification criteria for systemic sclerosis: An american college of rheumatology/European league against rheumatism collaborative initiative

    Frank Van Den Hoogen;Dinesh Khanna;Jaap Fransen;Sindhu R. Johnson

  • Nintedanib for Systemic Sclerosis-Associated Interstitial Lung Disease.

    Oliver Distler;Martina Gahlemann;Toby M Maher

  • Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

    Anthony J. Tyndall;Bettina Bannert;Madelon Vonk;Paolo Airò

  • Update of EULAR recommendations for the treatment of systemic sclerosis

    Otylia Kowal-Bielecka;Jaap Fransen;Jerome Avouac;Mike Becker;Mike Becker

  • Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis

    Alfiya Akhmetshina;Katrin Palumbo;Clara Dees;Christina Bergmann

  • Anti–Tumor Necrosis Factor-α Treatment Improves Endothelial Function in Patients With Rheumatoid Arthritis

    David Hürlimann;Adrian Forster;Georg Noll;Frank Enseleit

  • Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study

    J Gerry Coghlan;Christopher P Denton;Ekkehard Grünig;Diana Bonderman

  • Synovial fibroblasts: key players in rheumatoid arthritis

    L. C. Huber;O. Distler;I. Tarner

  • Mapping and predicting mortality from systemic sclerosis

    Muriel Elhai;Christophe Meune;Marouane Boubaya;Jérôme Avouac

  • Mortality in pulmonary arterial hypertension: prediction by the 2015 European pulmonary hypertension guidelines risk stratification model

    Marius M Hoeper;Tilmann Kramer;Zixuan Pan;Christina A Eichstaedt

  • MicroRNA-29, a key regulator of collagen expression in systemic sclerosis.

    Britta Maurer;Joanna Stanczyk;Astrid Jüngel;Alfiya Akhmetshina

  • Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial.

    Dinesh Khanna;Celia J F Lin;Daniel E Furst;Jonathan Goldin

  • Angiogenic and angiostatic factors in the molecular control of angiogenesis.

    J H W Distler;A Hirth;M Kurowska-Stolarska

  • Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis

    Dinesh Khanna;Daniel E. Furst;Philip J. Clements;Yannick Allanore

  • Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group

    Jérôme Avouac;J. Fransen;U. A. Walker;V. Riccieri

  • Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: Results from the COMPERA registry

    Marius M. Hoeper;Doerte Huscher;H. Ardeschir Ghofrani;Marion Delcroix

  • Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

    Suzana Jordan;Jörg H W Distler;Britta Maurer;Dörte Huscher

  • Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis

    Jörg H. W. Distler;Astrid Jüngel;Lars C. Huber;Ursula Schulze-Horsel

  • Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database

    Florian M P Meier;Klaus W Frommer;Robert Dinser;Ulrich A Walker

  • Uncontrolled Expression of Vascular Endothelial Growth Factor and Its Receptors Leads to Insufficient Skin Angiogenesis in Patients With Systemic Sclerosis

    Oliver Distler;Jörg H. W. Distler;Annette Scheid;Till Acker

Frequent Co-Authors

Jörg H W Distler
Jörg H W Distler University of Erlangen-Nuremberg
Yannick Allanore
Yannick Allanore Université Paris Cité
Marco Matucci-Cerinic
Marco Matucci-Cerinic University of Florence
Christopher P. Denton
Christopher P. Denton University College London
Georg Schett
Georg Schett University of Erlangen-Nuremberg
Ulf Müller-Ladner
Ulf Müller-Ladner University of Giessen
Dinesh Khanna
Dinesh Khanna University of Michigan–Ann Arbor
Gabriela Riemekasten
Gabriela Riemekasten University of Lübeck
Beat A. Michel
Beat A. Michel University of Zurich
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always mean attending a traditional medical school. The rise of online healthcare programs has opened alternative pathways for students looking to advance their careers or enter specialized fields conveniently and often at lower costs.

For those interested in advanced nursing careers, pursuing the cheapest dnp program can lead to higher salaries and leadership roles in clinical settings. Similarly, pharmacists now have the option to attend online pharmacy schools, offering flexibility without compromising on educational quality.

If you have a knack for managing health data, earning a him degree online prepares you for roles in the rapidly growing field of health information management. Alternatively, those looking for quicker entry into healthcare can obtain a medical billing and coding certification online and start working in administrative roles in clinics or hospitals.

These online degrees and certifications pave the way for diverse medical careers, offering flexibility, affordability, and access to high-demand professions in the U.S. healthcare sector.

Best Scientists Citing Oliver Distler

Trending Scientists

Recently Published Articles